BioTime and its wholly owned subsidiary, LifeMap Sciences, have announced an agreement to purchase XenneX. The acquisition, which is expected to close within 30 days, will merge XenneX into LifeMap Sciences. The deal is expected to ...
Tags: BioTime, XenneX, LifeMap Sciences
LifeMap Sciences, a subsidiary of BioTime, has introduced a database platform of human cellular life to advance research in the stem cell and other biomedical fields, and develop new diagnostic technologies and therapeutic products. The ...
Medistem and Superview Biotechnology, a subsidiary of Yinhuan Holding Co from Yixing, collaborate for the development of therapeutics using antibody and stem cell technology. The collaboration will leverage proprietary stem cell lines ...
Tags: therapeutics, antibody and stem cell technology, regenerative medicine
ViaCyte has received a $10.1m strategic partnership award from the California Institute for Regenerative Medicine (CIRM) to develop VC-01, which is a regenerative medicine, consisting of pancreatic beta cell progenitors in a durable ...
Tags: ViaCyte, Diabetes Therapy Development, CIRM
Life Technologies Corporation's OpTmizer CTS T-Cell Expansion Tissue Culture Medium has received FDA 510(k) clearance as a Class II medical device to transit studies from the research bench to clinical trials. The OpTmizer CTS, as a ...
Tags: FDA, clinical technology, clinical trials
Dohmen has completed the acquisition of a provider of quality assurance and regulatory affairs consulting services, Reglera. The acquisition will enable Dohmen to integrate Reglera's consulting services as well as outsource services. ...
US-based Life Technologies has developed a new molecular test for the detection of multiple strains of E.coli in ground beef. According to the company,the new test simultaneously detects E.coli O157:H7 and six non-O157 E.coli ...
Tags: molecular test, E.coli, ground beef, food safety, animal health